Mafalda Oliveira, Melissa Kate Accordino, Andres Cervantes, Valentina Gambardella, Erika P. Hamilton, Antoine Italiano, Komal L. Jhaveri, Dejan Juric, Kevin Kalinsky, Ian E. Krop, Cristina Saura, Peter Schmid, Nicholas C. Turner, Andrea Varga, Yanling Jin, Samuel Lim, Stephanie Royer-Joo, Noopur Shankar, Jennifer Schutzman, Philippe Bedard. "Phase I/Ib study of inavolisib (INAVO) alone and in combination with endocrine therapy ± palbociclib (PALBO) in patients (pts) with
            <i>PIK3CA</i>
            -mutated, hormone receptor–positive, HER2-negative locally advanced/metastatic breast cancer (HR+, HER2– LA/mBC): Analysis of hyperglycemia (HG) in prediabetic/obese pts.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.1004